To facilitate the investigation of the direct interaction between hematopoietic progenitors and colony-stimulating factors, we have developed a method t o purify human marrow progenitor cells. Using density centrifugation, negative panning with concanavalin A coated plates, positive selection of CD34-positive cells with immunomagnetic microspheres, overnight adherence t o a plastic dish, negative selection with a panel of monoclonal antibodies, and density centrifugation, human marrow progenitor cells were purified from 1.5% to 53.2%. a 42-fold purification, with a 4.8% yield. The purified cells consisted of 38% erythroid, 9% colony forming unit-granulocyte (CFU-G), 29% CFU-macrophage (CFU-M), 12% CFU-eosinophiVbasophil (CFU-Eo/Ba), and 4% CFU-mix. The purified cells cultured in serum-free fibrin URIFICATION of immature hematopoietic progeni-P tor cells will enhance the study of the molecular basis of progenitor cell development through a better understanding of the relationship between progenitor cells and their supporting cells and by providing a capacity to study a variety of hematopoietic growth factor receptors. Spangrude et a1 have reported a method for purifying pluripotential lymphohematopoietic stem cells from mouse bone marrow.' In humans, we have previously reported a method for purifying human progenitor cells from 400 mL of peripheral blood using monoclonal antibodies (MoAbs), including CD34, and immunomagnetic microspheres.' This method made it possible to purify human hematopoietic progenitor cells up to a purity of 70%, but it might not be useful for the study of the biology and pathophysiology of progenitor cells in very anemic patients. Therefore, we have developed a method for purifying human marrow progenitor cells using immunomagnetic microspheres. Ema et al have purified human marrow progenitor cells up to 37%, but their method uses fluorescent-activated cell-sorting (FACS) for the selection of CD34' cells.3 Because of the limitation of experimental time and of cell sorters, we developed a quite different method to select marrow CD34' cells.
Macrophage colony-stimulating factor (M-CSF) has well known effects on murine bone marrow,4.' but it has been difficult to show any appreciable effect on the growth of colony-forming unit-macrophage (CFU-M) from human bone Even with highly purified marrow progenitor cells, the undefined factors in serum might alter the growth factor requirements of progenitor cells, and M-CSF is present in normal human serum at a concentration of 550 f 110 U/mL.6 Therefore, we applied a serum-free medium to culture these cells.
In this report, we describe the purification method, and the direct action of M-CSF on CFU-M development using the combination of a serum-free medium, highly purified human marrow progenitor cells, and the technique of limiting dilution analysis.
clots with recombinant human macrophage colony-stimulating factor (rM-CSF) for 14 days developed a pure population of CFU-M colonies. An appearance of CFU-M colonies was present after the addition of 1 U/mL of rM-CSF and the maximum stimulation was found at 100 U/mL. When the purified cells were cultured in serum-free medium with rM-CSF in a limiting dilution assay and the percentage of nonresponder wells for CFU-M colonies was plotted against cell concentration, serum-free cultures yielded a straight line through the origin, indicating that CFU-M development did not depend on accessory cells and that rM-CSF acted directly on the CFU-M.
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MATERIALS AND METHODS
Cell separation by density centnfugation. Bone marrow samples were obtained from healthy adult volunteers with informed consent and 3 mL was collected in sodium heparin at a final concentration of 50 UlmL. The samples were well mixed with 5 mL of Dulbecco's phosphate-buffered saline (PBS) containing 13.6 mmol/L sodium citrate, and the light-density mononuclear cells were separated over Ficoll-Hypaque (FH; 1.077 g/cm', Pharmacia Fine Chemicals, Piscataway, NJ) at 40& 24"C, for 25 minutes.'The interface mononuclear FH cells were collected and washed with Iscove's modified Dulbecco's medium (IMDM) containing 0.25% deionized' bovine serum albumin (BSA, Sigma Chemical Co, St Louis, MO; Cohn fraction V, 96% to 99% pure) by centrifugation at 600g for 10 minutes at 24°C. The cell pellet was resuspended in 10 mL of IMDM containing 0.25% BSA and centrifuged at 600g for 5 minutes at 4°C and resuspended in IMDM containing 1% BSA at a concentration of 2 X 106/mL (FH cells).
SAT0 ET AL
Negative panning with concanavalin A-coated plates. Each 10 mL of FH cell suspension was incubated at 4°C for 45 minutes in 100-mm polystyrene tissue culture dishes (Corning; Iwaki Glass, Tokyo, Japan) that had been previously coated with concanavalin A (type IV; Sigma). The nonadherent cells were removed and centrifuged (Con A-cells). The preparation of concanavalin A-coated plates was performed by the method of Wysocki and Sato.' Polystyrene tissue culture dishes (100 x 20 mm) were incubated at room temperature with 10 mL of 0.05 mol/L Tris-HCI buffer, pH 9.5, containing 250 pg of concanavalin A. After 3 hours, the plates were washed three times in PBS, pH 7.4, once in PBS containing 0.1% BSA, and were then stored at -40°C until they were used.
The positive selection procedure of CD34-positive (CD34') cells was performed by the method described by Sawada et a12 with minor modifications. The Con A-cells were resuspended in IMDM containing 1.0% BSA at a concentration of 3 X 107/mL, cooled to 4"C, and mixed with the same volume of CD34/anti-MylO mouse hybridoma tissue culture supernatant at 4°C to coat lympho-hematopoietic progenitor cells.l"." The cell suspension was incubated at 4°C using an end-over-end rotator (Bel-art rotator, Model 71; TechniLab Instruments Inc, Pequannock, NJ). After 30 minutes of incubation, the cell suspension was transferred to a 15" conical tube (Becton Dickinson and Co, Lincoln Park, NJ) and 1.5 mL of 10% BSA was gently underlaid. The tube then was centrifuged at 400s for 5 minutes at 4°C. The anti-My10 hybridoma supernatant and approximately 0.5 mL of 10% BSA were removed, leaving 1 mL of 10% BSA in the tube. The tube wall then was washed once by gentle application of 5 mL of IMDM containing 0.25% BSA, while the rest of the 10% BSA over the cell pellet was used to protect the cells from the washing procedure (cell protection washing procedure). After washing the tube wall, the 10% BSA over the cell pellet was removed, and the cells were washed once with cold IMDM containing 0.25% BSA. The cells were resuspended in IMDM containing 1.0% BSA at a concentration of 3 x 107/mL in a 12 x 75 mm polystyrene tube (Becton Dickinson) and were incubated with immunomagnetic microspheres (Dynabeads M-450 coated with goat antimouse IgG; Dynal Inc, Great Neck, NY), with a microsphere per cell ratio of 3:1, at 4°C using an end-over-end rotator. After 50 minutes of incubation, the cell-bound microspheres and free microspheres were attached to the tube wall by a magnet (Dynal MPC-1; Dynal Inc, Fort Lee, NJ), and the free cells that did not bind microspheres were removed by washing the tube three times with 3 mL of cooled IMDM containing 0.25% BSA. The tube was then disconnected from the magnet and the microspheres were washed by gentle pipetting with 3 mL of cooled IMDM to remove BSA. The microspheres were again attached to the tube wall using the magnet, and cells released by washing were removed. The tube wall was washed once with cooled IMDM. The cells that bound microspheres and free microspheres were gently pipetted for 30 seconds with 1.5 mL of IMDM containing 130
Positive selection of cells coated with CD34.
UimL of chymopapain (Chymodiactin; Boots Company Inc, Lincolnshire, IL) and 0.02 mol/L disodium ethylenediamine tetraacetate (EDTA, Wako Chemicals, Osaka, Japan) at 37°C. The tube was attached to the magnet for 1 minute at 24°C. The cells released from the microspheres were collected and designated as CD34t fraction (Fr) 1. The CD34+ Fr 1 was immediately mixed with 4.5 mL of heat-inactivated fetal calf serum (FCS; Flow Laboratories, Inc, McLean, VA) at 24°C in a 15" conical tube to dilute the chymopapain activity. This separation procedure was sequentially repeated another two times to collect CD34' Fr 1 to 3 and the cells were pooled in the same tube containing FCS. After the cell protection washing procedure was performed, the cells were collected and resuspended in IMDM containing 0.25% BSA (CD34t cells).
The CD34' cells were incubated overnight, at 3TC, in 5 mL IMDM containing 20% FCS, 10% heat-inactivated pooled human AB serum, 1% BSA, 50 U/mL of recombinant human interleukin-3 (rIL-3) (10' U/mg; AmGen Biologicals, Thousand Oaks, CA), 50 U/mL of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) (4.5 x lo7 U/mg; Schering Research, Bloomfield, NJ), 50 U/mL of recombinant human granulocyte-CSF (rG-CSF) (2.5 x lo' Uimg; Chugai Pharmaceutical Co, Tokyo, Japan), 2 U/mL of recombinant human erythropoietin (rEP) (146,000 Uimg; Snow Brand Co, Tokyo, Japan), 10 @ n L insulin (porcine sodium, activity 26.3 USP Uimg; Calbiochem, Behring Diagnostics, La Jolla, CA), 5 x mol/L 2-mercaptoethanol (2-ME Sigma), penicillin at 50 UlmL, and streptomycin at 50 pg"L (Flow Laboratories) in a 25-cm2 tissue culture polystyrene flask (Becton Dickinson) placed into a 5% C02/95% atmosphere incubator. The nonadherent day 1 cells were removed with gentle washes and centrifuged (ADcells).
The ADcells were suspended in 0.84 mL IMDM containing 1.0% BSA in a 2-mL tube (Sarstedt, Rommelsdorf, Germany), cooled to 3"C, and the mouse MoAbs listed in Table 1 were added to coat granulocytes, monocytes, natural killer cells, T or B lymphocytes, at the final concentrations
The final volume of the cell suspension was 1 mL, which was incubated for 30 minutes at 3°C with end-over-end rotation before being transferred to a 15" conical tube for the cell protection washing procedure. After removal of the rest of the 10% BSA, the cells were washed once with 10 mL IMDM containing 0.25% BSA at 4°C. The cells were resuspended in 2 mL IMDM containing 1.0% BSA and then were mixed with immunomagnetic microspheres coated with goat antimouse IgG with a ratio of 40:l in a 12 x 75 mm polystyrene tube (Becton Dickinson). The tube was incubated with an end-over-end rotator at 3°C. After 60 minutes, the cells that did not bind microspheres were collected by magnetic separation (AB-cells).
The AB-cells were resuspended in 2 mL IMDM containing 0.25% BSA and were overlaid on FH in a 12 X 75 mm polystyrene tube. After centrifugation at 600g with rapid Adherent cell depletion.
Antibody-coated cell depletion by negative selection.
Removal of dead cells. (AB-FH cells) were collected into a 15" conical tube for the cell protection washing procedure. The rest of the 10% BSA then was removed, and the cells were resuspended in IMDM containing 0.25% BSA to be kept at 3°C until use. The viability of these cells was measured by dye exclusion using 0.2% trypan blue dye.I4
Aliquoted cells from each fraction were cultured in triplicate at various concentrations ranging from 5 x 10' to 2 x lo5 cellsimL in 24-well flat-bottomed tissue culture plates (Linbro; Flow Laboratories) with a 0.5 mL mixture containing 20% FCS, 10% pooled human AB serum, 1% BSA, 5 x mol/L 2-ME, 1.5 mmol/L eaminocaproic acid (EACA; Kishida Chemical Co, Osaka, Japan), penicillin-streptomycin, 10 p,g/mL insulin, rEP at 2 UimL, rIL-3 at 50 UimL, rGM-CSF at 50 U/mL, rG-CSF at 50 UlmL, 2 mg/mL human fibrinogen (grade L, coagulability 90% of total protein content; KabiVitrum, Stockholm, Sweden), 0.2 UimL thrombin (Parke-Davis, Morris Plains, NJ), and IMDM. For serum-free culture, FCS and pooled human AB serum were substituted by 300 p,g/mL of iron-saturated transferrin (purity 98%; Sigma) and lipid suspension (oleic acid, 2.8 p,g/mL; L-a-phosphatidylcholine, 4.0 pg/mL; cholesterol, 3.9 pg/mL; Sigma) as described previo~sly.'~ After 14 days of incubation at 37°C in a 5% C02/95% atmosphere, the clots were fixed and stained. rM-CSF (2.1 x lo6 Uimg) was a gift of Genetics Institute (Cambridge, MA). After benzidine-hematoxylin staining: enumeration of burst-forming unit-erythroid (BFU-E) was performed in accordance with the criteria of Clark and Housman.' The colonies that gave rise to 8 to 49 erythroblasts after 14 days of culture were counted as small erythroid (SE) colonies. The colonies that gave rise to 40 or more nonhemoglobinized cells were counted as nonerythroid colonies, while the colonies that gave rise to 40 or more nonhemoglobinized cells with 100 or more hemoglobinized cells and the colonies that gave rise to typical BFU-E bursts with 20 or more nonhemoglobinized cells were counted as erythroid-mix. Nonerythroid colonies that gave rise to 40 or more cells were classified to CFU-granulocyte (CFU-G), CFU-M, or CFUeosinophiUbasophi1 (CFU-Eo/Ba) using a-naphthyl butyrate esteraseiAS-D chloroacetate esterase,'6 astra blue-eosin," or MayGriinwald-Giemsa staining. The colonies that gave rise to 40 or more cells with more than 30% of cells in different lineage were counted as nonerythroid-mix. CFU-M formed smaller colonies in serum-free medium as compared with those formed in serumcontaining medium. Therefore, in serum-free medium, the colonies that gave rise to 20 or more macrophages were counted as CFU-M colonies, while the colonies that gave rise to 10 to 19 macrophages were counted as CFU-M clusters.
Cultureprocedure forprogenitor cells.

RESULTS
Purification of hematopoietic progenitor cells from human marrow. Table 2 shows the mean yield and enrichment of human marrow progenitor cells in seven experiments when FH mononuclear cells were sequentially purified by negative panning with concanavalin A-coated plates (Con A-) , positive selection of the cells bearing the CD34 surface marker (CD349, depletion of adherent cells (AD-), negative selection of the cells bearing surface markers for the MoAbs listed in Table 1 (AB-), and the depletion of dead cells (AB-FH). To determine the number of progenitor cells, each fraction was cultured in serum-containing fibrin clots for 14 days. Through these procedures, human marrow progenitor cells were purified from 1.5% k 0.7% (FH) to 53.2% 2 6.51% (AB-FH), with a range of 45% to 67%, a &?-fold purification with a 4.8% yield and 97% 2 3% viability. When AB-FH cells were cultured for 7 days with rEP, they promoted CFU-erythroid (CFU-E) that gave rise to 8 to 49 cells's (data not shown). However, in this report, we did not add the purity of CFU-E in Table 2 because of the difficulty in distinguishing CFU-E that gradually degraded and declined in the clots8 from small erythroid colonies that were retained for 14 days in the clots. By light microscopy, AB-FH cells consisted predominantly of very immature blast cells (Fig 1A) .
This purification method is characterized by positive selection of CD34' cells using immunomagnetic microspheres coated with goat antimouse IgG and the release of microspheres from CD34' cells for further purification steps. A representative experiment is shown in Fig 2A. In the CD34-Fr 1,68% of the progenitors in the Con A-cell fraction were released; however, 93% of released progenitor cells gave rise to small erythroid colonies. The CD34-Fr 5 was pipetted with IMDM to remove BSA and, as a result, 11% of the progenitors in the Con A-cells were released, but 58% of the released progenitor cells gave rise to small erythroid colonies. The mixture was then treated with chymopapain to release the cells from the microspheres. CD34' Fr 1 to 3 contained 12% of the total progenitor cells, including small erythroid colony progenitors in the Con Acells and 52% of erythroid-mix, BFU-E, and nonerythroid progenitor cells in the Con A-cells. Table 1 (AB-), and density centrifugation (AB-FH). The cells from each fraction were cultured in triplicate in 0.5 mL fibrin clots at a range of concentrations of 50 to 20,000 cells/mL with 2 U/mL of rEP, 50 U/mL of rlL-3,50 U/mL of rGM-CSF, and 50 U/mL of rG-CSF. Mean values for seven experiments f SD are shown.
Human marrow progenitor cells were purified from 3 mL blood using density centrifugation (FH), negative panning with concanavalin A-coated plates (Con A-), positive selection with CDBWanti-My10 MoAb (CD34+), adherent cell depletion (AD-), negative selection with MoAbs listed in
For The effect of negative selection and the yield and purity of the progenitor cells in each fraction are shown in Fig 2B. The AB-Fr 1 that had not been suspended by gentle pipetting contained 74% of the progenitor cells with a purity of 52%. The purity of the progenitor cells was dramatically decreased in the A € -Fr 2 after gentle pipetting. Therefore, in the negative panning procedure, only AB-Fr 1 was collected and used.
To investigate the lineage of the progenitor cells in the purified cells, AB-FH cells were cultured with rIL-3, rGM-CSF, rG-CSF, and rEP in serum-containing medium, and with rIL-3, rGM-CSF, rG-CSF, rM-CSF, and rEP in serum-free medium, as shown in Table 3 . The progenitor cells in the AB-FH cells contained cells that gave rise to 1% erythroid-mix, 29% BFU-E, 16% small erythroid, 3% nonerythroid-mix, 9% CFU-G, 29% CFU-M, and 12% CFU-Eo/Ba colonies. When rM-CSF was added to the serum-free medium, the AB-FH cells expressed the same number of colonies with the same lineage expression as those observed in serum-
Lineage ofprogenitor cells in purified cells.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org Table 1 t o coat contaminant cells, and the cells that did not have microspheres were collected using the magnet and designated as AB Fr 1. The microsphere-cell mixture was then suspended by gentle pipetting ( 0 1, and the cells that did not have microspheres were collected as AB Fr 2. This washing procedure was repeated t o collect AB Fr 3 and 4. The cells of each fraction were cultured in triplicate in fibrin clots with rlL-3 at 50 U/mL, rGM-CSF at 50 U/mL, rG-CSF at 50 UlmL, and rEP at 2 U/mL t o determine the purity of progenitor cells. After 14 days, the clots were fixed and stained with benzidine/hematoxylin and erythroid-mix (B), BFU-E (0). small erythroid (: .), and nonerythroid (: :) colonies were classified.
containing mcdium. By astra bluc-eosin staining, two typcs of eosinophil colonics wcrc obscrvcd. Onc group consistcd of eosinophils and basophils. Thc othcr group consistcd of cclls staincd by both astra bluc and cosin (data not shown). The purified cells (AB FH) were cultured in triplicate in 0.5 mL serum-containing medium at a concentration of 200 cellslmL in the presence of 50 UlmL of rlL-3.50 U/mL of rGM-CSF, 50 U/mL of rG-CSF, and 2 UlmL of rEP. Cell aliquots were also plated into serum-free medium with 100 UlmL of rlL-3, 100 U/mL of rGM-CSF, 100 UlmL of rG-CSF, 100 UlmL of rM-CSF, and 2 UlmL of rEP. After 14 days of culture, clots were fixed and stained with May-Grirnward-Giemsa, and the number of the colonies in each lineage was counted. Each value is the mean f SD of six experiments and is expressed as a percentage of the value obtained in serum-containing cultures that gave rise to 51 f 4 coloniedlO0 AB FH cells and in serum-free cultures that gave rise to 44 f 6 colonies/100 AB FH cells.
Thcrcforc, in this rcport, we did not scparatc CFU-Eo from CFU-Ba and countcd thc colonics as CFU-Eo/Ba colonies.
Thc serum-containing mcdium supportcd CFU-M colonics without thc addition of rM-CSF, whilc thc addition of rM-CSF was ncccssary for the scrum-frcc mcdium to obtain full CFU-M colony cxprcssion (Table 3) , and without rM-CSFvcry few CFU-M colonies wcrc cxprcsscd. To addrcss this discrepancy and to invcstigatc whcthcr rM-CSF alone can promotc CFU-M colonics in scrum-frcc medium, dose-rcsponsc cxpcrimcnts with rM-CSF wcrc pcrformcd in both scrum-containing and scrum-frcc mcdium.
As shown in Fig 3, in serum-frcc culture, an increase in thc numbcr of CFU-M colonies was prcscnt aftcr thc addition of 1 U/mL of rM-CSF and a plateau was cvident at 100 U/mL. Thc colonics promotcd by the addition of rM-CSF prcdominantly consistcd of CFU-M colonics as shown in Fig IB. No colonies werc prcscnt without thc addition of rM-CSF, whilc 67% of the maximum numbcr of CFU-M colonics wcrc prcscnt without the addition of rM-CSF in scrum-containing mcdium (Fig 3) .
The relation bctwccn thc number of CFU-M colonies and thc numbcr of purificd marrow progenitor cclls (AB-FH cclls) platcd in scrum-frcc mcdium in a conccntration range of 50 to 800 cclls/mL was a straight linc through the origin, suggcsting a clonal basis for CFU-M development (Fig 4) . Relation between the number of CFU-M colonies and the number of the purified marrow cells (AB-FH) plated. The cells that contained 53% 2 2% total progenitor cells were plated in 0.5 mL serum-free fibrin clots in concentrations of 50 t o 800 cells/mL with 100 U/mL of rM-CSF. After 14 days of incubation, the clots were fixed, stained by a-naphthyl butyrate esterase-hematoxylin, and the number of esterase positive colonies were counted as CFU-M colonies. Each value is the mean 2 SD of three triplicates. Negative panning with concanavalin A-coated plates was devised to enrich progenitor cells without antibodies before CD34-positive selection. While the purification factor by Con A-negative panning was relatively low, at 1.6-fold, this had an excellent yield at 99% ? 22%. We do not know the exact mechanism of enrichment by Con A-negative panning, but based on a trial of other similar reagents, such as phytohemagglutinin, soybean agglutinin, pockweed mitogen, and a combination of these, concanavalin A alone was selected because it provided the highest purification factor and yield.
Growth characteristics of CFU-M,
The introduction of microspheres and the use of chymo- For personal use only. on October 24, 2017. by guest www.bloodjournal.org From papain to release microspheres from CD34' cells is based on the report by Civin et a].' ' Chymopapain is known to break the hinge region of Ig.21 When a single incubation was used and varying times and concentrations were tested for removing CD34' cells, the results varied widely from experiment to experiment (data not shown). The main reason for this instability appeared to be a narrow difference between the pharmacologic capacity of chymopapain to free CD34' cells and to lyse them. Therefore, we devised a fractionation method with repeated short incubations, and this made it possible to stabilize the recovery and viability of the progenitor cells.
AB-FH CELLS
Because the MoAbs used for negative panning were selected empirically, there may be other efficient combinations, but when we tried anti-My31 (CD56) and anti-IL-2 receptor (CD25) MoAb, with the combination listed in Table 1 , no increment of progenitor cell purity was obtained. The addition of anti-OKT4 (CD4), anti-My1 (CD15), and anti-My11 (CD45R) reduced the purity of the progenitor cells.
The purified marrow cells contained most of the known progenitor cells, such as CFU-M, CFU-G, CFU-Eo/Ba, BFU-E, small erythroid, erythroid-mix, and nonerythroidmix ( Table 3) . CFU-megakaryocyte (CFU-Meg) could be detected and represented up to 3% of the progenitor cells in serum-containing medium, using IIb/IIIa MoAb staining** (data not shown). Serum-free medium supported 87% ? 11% colony growth, with the same lineage proportion as serum-containing medium (Table 3 ). There was no significant difference in plating efficiency between serumfree and serum-containing medium, but serum-free medium failed to support CFU-Meg colony expression by purified cells.
CFU-M colonies can be induced from murine marrow cells by human M-CSF.4,5 In contrast, it has been difficult to show striking evidence of CFU-M stimulation by M-CSF in human bone marr0w.4~' The expression of CFU-M colonies by human bone marrow cells indicated the presence of progenitors for CFU-M c o l~n i e s ,~~~'~ but the effect of M-CSF on CFU-M colony formation was within the minimum range.435 It has been reported that myeloid cells or monocytes in the marrow inhibit CFU-M colony format i~n , '~ and that M-CSF is present in serum. 6 To investigate whether M-CSF stimulates CSF-M colony expression, we combined two methods, using highly purified marrow progenitor cells and a serum-free culture system.
As shown in Fig 3, the presence of serum promoted CFU-M colopies by highly purified marrow cells without the addition of rM-CSF, apd with little additional stimulation of CFU-M colonies by the addition of rM-CSF. However, in serum-free medium, the effect of rM-CSF on human marrow progenitor cells was apparent. The positive correlation between the number of CFU-M colonies and the number of purified marrow progenitors indicated a clonal basis for CFU-M development (Fig 4) and this was further investigated using limiting dilution analysis (Fig 5) . Even though our marrow progenitor cells were purified to 45% to 67% of the cell population, the effect of added rM-CSF could still occur through an indirect stimulation of the remaining contaminant cells. Therefore, we applied the technique of limiting dilution analysis to identify the presence of an accessory cell mechanism. When the number of purified cells with rM-CSF was plotted against the logarithm of the percentage of CFU-M colony-negative and/or CFU-M cluster-negative wells, a straight line through the origin was apparent, indicating that clonal growth was unaffected by the presence of additional cells and only dependent on the CFU-M itself. The present limiting dilution studies, which show a single hit curve, indicate that a single cell population is involved and that M-CSF acts directly on the CFU-M.
The colony size of CFU-M that we observed in serumfree medium was smaller than that reported by other investigator^.^^^ One possibility is that our studies might be limited to an effect of M-CSF on the more mature progenitors rather than the CFU-M. But when the lineage of the purified marrow progenitors was examined by the addition of rIL-3, rGM-CSF, rG-CSF, rM-CSF, and rEP, the serumfree medium expressed the same percentage of CFU-M colonies compared with those observed in serum-containing medium (Table 3) . For this reason, we suspect that some nutritional defect is present in our serum-free medium, not for CFU-M colony expression, but for macrophage proliferation.
In conclusion, we have established a method for purifying human marrow progenitor cells, and using the combination of a serum-free medium, highly purified human marrow progenitors, plus the technique of limiting dilution analysis, we have found that M-CSF acts directly on CFU-M. The purification method presented here is relatively easy to apply in any laboratory with limited expense and laboratory time. With the use of serum-free medium, more precise investigations on the effect of growth factors on progenitor cells can be undertaken than with unpurified marrow cells. It is now also possible to study the pathophysiology of highly purified progenitor cells in a variety of clinical anemias.
